Lancet Infect Dis:中国社区药房无处方处方药销售情况仍不容乐观

2019-10-04 MedSci MedSci原创

研究发现,中国社区药店的无处方处方药销售情况仍较为普遍,需要采取多方面的措施,包括管制措施、专业培训和公共卫生教育,规范处方药,特别是抗生素的销售

社区药店中无处方抗生素销售是抗菌药物耐药性的主要驱动因素。近日来,中国已将遏制社区药房无处方药物销售作为解决抗生素耐药性的一项重要任务,并计划在2020年前在全国范围内消除这一现象。近日研究人员对2017年中国社区药房的无处方药物配药量进行量化,并对单个省份的纵向(2011-17年)抗生素配药量进行量化。

研究人员对社区药店中儿童腹泻和成人急性上呼吸道感染(URTI)的无处方抗生素配药情况进行考察。收集了中国6个省、221个县或地区的2411家社区药房数据,并在2011年对陕西省213家社区药房进行了基线调查,随后每2年进行一次随访调查。

2411个参与研究的药店中,1169个存在无处方儿童腹泻(48.5%)抗生素销售,1690个存在无处方URTI抗生素销售(70.1%)。无处方抗生素销售在农村和中西部省份更为普遍,与配有驻店药师 (OR=0.66)和连锁药店(0.75)呈负相关。2011-2017年间,陕西省儿童腹泻 (从213家社区药房中154家[72.3%]降至107家[50.2%])和URTI(从204家[95.8%]降至148家[69.5%]) 无处方抗生素配药量显著下降。

研究发现,中国社区药店的无处方处方药销售情况仍较为普遍,需要采取多方面的措施,包括管制措施、专业培训和公共卫生教育,规范处方药,特别是抗生素的销售。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
    2022-03-12 医者仁者

    #处方药#这本来就是有争议的领域了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
    2020-07-23 yaanren
  3. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
    2020-08-10 howi
  5. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
    2019-10-29 sunmin0227
  6. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1201856, encodeId=52a2120185640, content=<a href='/topic/show?id=aed54243484' target=_blank style='color:#2F92EE;'>#处方药#</a>这本来就是有争议的领域了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42434, encryptionId=aed54243484, topicName=处方药)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sat Mar 12 00:37:33 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648805, encodeId=257b1648805e5, content=<a href='/topic/show?id=699b233e229' target=_blank style='color:#2F92EE;'>#乐观#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23372, encryptionId=699b233e229, topicName=乐观)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e79123671906, createdName=yaanren, createdTime=Thu Jul 23 15:37:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013085, encodeId=6bf8201308526, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Nov 02 12:37:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830277, encodeId=c0a418302e7b2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Aug 10 20:37:00 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654352, encodeId=fdcf165435229, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Tue Oct 29 09:37:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687354, encodeId=c080168e35475, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue Jul 21 13:37:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395846, encodeId=03db13958468e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Sun Oct 06 00:37:00 CST 2019, time=2019-10-06, status=1, ipAttribution=)]

相关资讯

处方获取三大模式研究:趋势已成,样板初现

随着医改逐渐深入,政策明确下的处方外流市场正呈加速趋势。业内预测至2020年前,院内处方药外流规模预计达到4000亿,院外购药渠道成为院内处方外流的重要承接。各方纷纷入局的同时问题频发,不合规的线上和线下处方药销售行为近日再次被推至浪尖。如何确保处方药销售时有合规的处方来源?作为购买处方药的主体,患者在实际购药过程中的处方合规获取是关键。

在线秒开处方、传图即发药……你敢这样买处方药吗?

网上提交购药申请,简单和在线医生沟通甚至无需经过医生,就可购买处方药。近年来,网络购药因为方便快捷受到不少人青睐,但因为操作过程中存在诸多审核漏洞,也让网络售药多了几重风险。医生如何判断患者病情?处方真实性如何保障?近期,记者就一系列关系患者切身利益的问题进行了调查采访。在某网上药店APP内,记者未提交处方也成功购得一盒阿莫西林胶囊。神操作:医生在线“秒开”处方、无方也能购药近期,媒体有关“宠

处方药随便买、“隔网神医”满天飞……网上药店该严管了

通过手机APP买药如今已成为新趋势。不过,记者调查发现,在没有提供医生开具的处方时,用户也可以在部分APP买到处方药;部分APP对处方药搞“满减促销”,鼓励消费者多买;买药APP的“在线医师”和“病友”随意提供用药指导……在享受方便快捷的同时,通过APP买药也存在诸多问题亟待整治和规范。方便快捷,网上买药成新趋势记者尝试在手机应用商店搜索关键词“买药”,可找到数十个在线买药APP,下载安装后,使用

互联网医疗将放开并纳入医保报销 处方药零售重要的契机

国家医疗保障局官网公开了对十三届全国人大二次会议部分代表关于互联网医疗建议提案的答复。答复中指出,互联网医疗收费政策已经形成初稿,未来会正式发布。互联网医疗纳入医保报销范围的工作也要进行之中。

“聪明药”到底是什么药?管控类处方药,电商销售随意

吃了就能变聪明、无副作用、能增加免疫力……近年来,每逢全国性各类考试前夕,一种号称“聪明药”的药品便在网络走俏,一些家长、学生热衷购买服用。“新华视点”记者调查发现,所谓“聪明药”属于国家严格管控的精神类处方药,不能随意购买。在相关部门屡次严打之下,一些药商转入地下,通过电商平台、社交媒体隐蔽销售。长期服用有诸多副作用在网络上,“聪明药”销售火爆,高峰期甚至出现断货。“平时利他林通常每粒卖16至3

处方药管理隐患转到线上 个别平台存在促销行为

处方药易得 规范性难保证处方药陪伴有胃病的王莉十多年了。从初中起,她就饱受胃痛的困扰,吃了“酸辣冷”的东西胃会痛,不吃早饭也会痛。疼痛来得突然而不可逆转。后来,姑姑和奶奶推荐她吃奥美拉唑肠溶片,她试了后果然有用。尽管从没有经过医生的诊治,她的包里还是一直常备着这种药。吃完了,就再去药店补货。她一次也没被要求出示处方。“每一次都很顺利,除非药店把药卖完了”。直到接受中国青年报·中国青年网记者采访